Screener
LABD vs TBXU
Direxion Daily S&P Biotech Bear 3X Shares vs Direxion Daily Biotech Top 5 Bull 2X ETF
Key differences
- TBXU costs 0.09% less per year.
- LABD is significantly larger than TBXU — larger funds tend to be more liquid and less likely to close.
- LABD follows a inverse strategy; TBXU uses leveraged.
- LABD has a longer track record, which may reduce uncertainty around long-term behavior.
Side-by-side comparison
| LABD | TBXU | |
|---|---|---|
| Annual cost (TER) | 1.07% | 0.98% |
| Fund size (AUM) | $69M | $3M |
| Since | 2015 | 2025 |
| Dividend yield | 6.38% | — |
| Asset class | equity | equity |
| Region | north america | north america |
| Strategy | inverse | leveraged |
| CAGR 1Y | -82.9% | N/A |
| CAGR 3Y | -50.8% | N/A |
| CAGR 5Y | -42.0% | N/A |
| Sharpe 3Y | -0.52 | N/A |
| Volatility 1Y | 74.72% | — |
| Max drawdown | -99.98% | -25.36% |
Green dot indicates the better value for that metric. Performance data is historical and does not predict future results.
Similar to LABD and TBXU
Explore further